三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图17.度普利尤单抗的不良反应发生率整体与安慰剂类似
图17.度普利尤单抗的不良反应发生率整体与安慰剂类似
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:183KB
图片尺寸:1771*829
同报告图片
/
4
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
5oqx5q2J77yM5oiR5peg5rOV5o+Q5Y+W5Zu+54mH5Lit55qE5pWw5o2u5bm255Sf5oiQ6KGo5qC844CC
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
所属报告:
医药生物行业疾病治疗专题研究~COPD领域出现新突破:COPD治疗出现突破机遇风险并存-250213(25页).pdf
打包全文图表
相关数据
度普利尤单抗(达必妥)全球销售额(2017-2025年)
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
收藏
行业数据
2026-05-28
原图定位
查看详情
英国建议或指导的发生率与资产规模的关系
收藏
市场规模
2026-04-20
原图定位
查看详情
表3.1. 尽管感染、预防和控制能力有限,保加利亚的医院感染发生率仍低于欧盟国家,显示出病例的低报告
收藏
竞争格局
2026-04-01
原图定位
查看详情
表6各国不良反应监测制度对比
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
收藏
行业数据
2026-03-23
原图定位
查看详情
图6-4 2022年各地区城乡贫困发生率
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
收藏
行业数据
2026-03-13
原图定位
查看详情
Ph3ORIGIN3研究中Atacicept及安慰剂组受试者第36周uPCR及Gd-IgA1数据
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
收藏
行业数据
2026-03-13
原图定位
查看详情
RC18针对SDESSDAI剔除安慰剂评分下降情况对比其他药物
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
收藏
行业数据
2026-03-13
原图定位
查看详情
图1.1:2010-2024年五岁以下儿童超重发生率的年增长率,2010-2024
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
收藏
行业数据
2026-03-04
原图定位
查看详情
图1 全球及亚洲和太平洋地区营养不良的发生率以及亚洲和太平洋地区的营养不良人数
fCDlubTku70gfCDppaXppb/mtYHooYznjofvvIjkuprmtLLlkozlpKrlubPmtIvlnLDljLrvvInvvIgl77yJIHwg6aWl6aW/5rWB6KGM546H77yI5YWo55CD77yJ77yIJe+8iSB8IOmlpemlv+S6uuaVsO+8iOS6mua0suWSjOWkquW5s+a0i+WcsOWMuu+8ie+8iOeZvuS4h++8iSB8CnwtLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgMjAwMCB8IDE0LjEgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTMuMCAgICAgICAgICAgICAgICAgICAgIHwgNDg1ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAwMSB8IDE0LjYgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTMuMiAgICAgICAgICAgICAgICAgICAgIHwgNTA1ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAwMiB8IDE0LjkgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTMuMyAgICAgICAgICAgICAgICAgICAgIHwgNTIwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAwMyB8IDE0LjggICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTMuMiAgICAgICAgICAgICAgICAgICAgIHwgNTI1ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAwNCB8IDE0LjcgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTMuMCAgICAgICAgICAgICAgICAgICAgIHwgNTMwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAwNSB8IDE0LjIgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTIuNSAgICAgICAgICAgICAgICAgICAgIHwgNTE1ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAwNiB8IDEzLjIgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTEuOCAgICAgICAgICAgICAgICAgICAgIHwgNDgwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAwNyB8IDExLjggICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAuOCAgICAgICAgICAgICAgICAgICAgIHwgNDMwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAwOCB8IDEwLjggICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOS45ICAgICAgICAgICAgICAgICAgICAgIHwgNDAwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAwOSB8IDEwLjUgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOS41ICAgICAgICAgICAgICAgICAgICAgIHwgMzk1ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxMCB8IDkuOCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOS4wICAgICAgICAgICAgICAgICAgICAgIHwgMzgwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxMSB8IDkuMiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOC43ICAgICAgICAgICAgICAgICAgICAgIHwgMzY1ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxMiB8IDkuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOC41ICAgICAgICAgICAgICAgICAgICAgIHwgMzYwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxMyB8IDguNyAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOC4yICAgICAgICAgICAgICAgICAgICAgIHwgMzUwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxNCB8IDguMyAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOC4wICAgICAgICAgICAgICAgICAgICAgIHwgMzMwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxNSB8IDguMSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNy45ICAgICAgICAgICAgICAgICAgICAgIHwgMzIwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxNiB8IDcuNSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNy42ICAgICAgICAgICAgICAgICAgICAgIHwgMzAwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxNyB8IDcuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNy40ICAgICAgICAgICAgICAgICAgICAgIHwgMjgwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxOCB8IDcuMSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNy41ICAgICAgICAgICAgICAgICAgICAgIHwgMjg1ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxOSB8IDcuMyAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNy43ICAgICAgICAgICAgICAgICAgICAgIHwgMjk1ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMCB8IDguMiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOC45ICAgICAgICAgICAgICAgICAgICAgIHwgMzQwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMSB8IDguNSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOS4xICAgICAgICAgICAgICAgICAgICAgIHwgMzU1ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMiB8IDguMyAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOS4wICAgICAgICAgICAgICAgICAgICAgIHwgMzUwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMyB8IDcuOSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOC44ICAgICAgICAgICAgICAgICAgICAgIHwgMzQwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyNCB8IDcuMiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOC41ICAgICAgICAgICAgICAgICAgICAgIHwgMzEwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrln7rkuo7nsq7lhpznu4Tnu4fjgIIyMDI15bm044CCRkFPU1RBVDog57Ku6aOf5a6J5YWo5oyH5qCH5aWX5Lu244CC5ZyoOiBGQU9TVEFU44CCW+iuv+mXruS6jjIwMjXlubQ35pyIMjjml6VdLiBodHRwczovL3d3dy5mYW8ub3JnL2Zhb3N0YXQvZW4vI2RhdGEvRlPjgILorrjlj6/or4E6IENDLUJZLTQuMA==
收藏
行业数据
2026-03-04
原图定位
查看详情
严重出血或临床相关的非严重出血事件发生率(AZALEA-TIMI71)
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
收藏
行业数据
2026-02-26
原图定位
查看详情
LBL-024联合化疗一线治疗晚期EP-NEC患者的不良反应情况
收藏
行业数据
2026-02-24
原图定位
查看详情
图 8-17 2023-2024年天津市居民伤害报告发生率(1/10万)
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
收藏
行业数据
2026-01-19
原图定位
查看详情
度普利尤单抗2024年销售额超140亿美元,持续快速放量中
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
收藏
行业数据
2025-12-26
原图定位
查看详情
截至2025年9月底,度普利尤单抗、司普奇拜单抗分别获批8项、3项适应症,且适应症持续拓展
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
收藏
行业数据
2025-12-26
原图定位
查看详情
地达西尼安全性和安慰剂相当
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
收藏
行业数据
2025-11-24
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
且两个研究中度普利尤单抗的安全性表现良好,整体发生情况与安慰剂组类似,以上结果表明度普利尤单抗在血嗜酸性粒细胞≥300 个/μL 的中重度伴 2 型炎症COPD 患者人群中表现出优异的疗效和良好的安全性,有可能成为未来 COPD 急性加重期患者治疗的基石药物。BOREAS 和 NOTUS 两项研究关于患者人群的筛选方法以及研究终点的确定也将成为未来一段时间针对 2 型炎症细胞因子的生物制剂攻克 COPD 的标杆性试验。
行业数据
原图定位
当前图表所属:
医药生物行业疾病治疗专题研究~COPD领域出现新突破:COPD治疗出现突破机遇风险并存-250213(25页).pdf
2026年 COPD治疗行业报告:度普利尤单抗获批,生物制剂研发格局与市场前景分析
表6.IL-4(R)/IL-13靶点针对COPD的在研药物
表3.国内COPD常用吸入治疗药物
表2.2018年二三级医院COPD诊疗现状调查
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》